BridgeBio Oncology Therapeutics Inc.
BBOT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $409 | $32 | $1 | $2 |
| Short-Term Investments | $60 | $100 | $0 | $0 |
| Receivables | $0 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $6 | $0 | $0 |
| Total Curr. Assets | $476 | $142 | $1 | $2 |
| Property Plant & Equip (Net) | $3 | $3 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $194 | $192 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $5 | $0 | $0 |
| Total NC Assets | $9 | $9 | $194 | $192 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $485 | $151 | $196 | $194 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $2 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $3 | -$2 | $0 |
| Total Curr. Liab. | $36 | $27 | $2 | $0 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $349 | $6 | $6 |
| Total NC Liab. | $2 | $352 | $6 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $0 | $0 |
| Total Liabilities | $38 | $379 | $7 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $194 | $192 |
| Retained Earnings | -$318 | -$273 | -$6 | -$4 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $447 | -$228 | $188 | $189 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $485 | $151 | $196 | $194 |
| Net Debt | -$409 | -$32 | -$1 | -$2 |